• Company
• K-CAB and Fexuclue, new P-CAB drugs, expand globally
• by Kim, Jin-Gu Feb 21, 2024 05:45am

• Policy
• President Yoon asks doctors to 'stop collective action'
• by Lee, Jeong-Hwan Feb 21, 2024 05:45am

• Company
• Sanofi Korea CEO Kyungeun Bae promoted to head 3 countries
• by Eo, Yun-Ho Feb 21, 2024 05:45am

• Company
• Keytruda leads mkt for 4 consecutive years
• by Chon, Seung-Hyun Feb 21, 2024 05:45am

• Company
• Samsung Bioepis will directly sell 3 of its biosimilars
• by Nho, Byung Chul Feb 20, 2024 06:00am

• Policy
• Multiple low-dose Kerendia Rx subject to reimb cuts
• by Lee, Tak-Sun Feb 20, 2024 06:00am

• Company
• Generic Pazeo sales 24%↑ after patent dispute win
• by Kim, Jin-Gu Feb 20, 2024 06:00am

• Company
• K-Pharma Bios jump into cancer vaccine development
• by Son, Hyung-Min Feb 19, 2024 05:45am

• Company
• Clopidogrel mkt exceeds KRW 500 bil for the first time
• by Kim, Jin-Gu Feb 19, 2024 05:45am

• Company
• K-made new stroke drugs accelerate towards commercialization
• by Son, Hyung-Min Feb 19, 2024 05:45am